BPD-DS also rapidly enhances insulin sensitivity—HOMA-IR improves within days postoperatively [57], and it achieves high rates of type 2 diabetes remission, addressing a key driver of NAFLD [51,54]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.